• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Peregrine Pharmaceuticals - Articles and news items

bavituximab

Bavituximab and durvalumab combo to be evaluated in solid tumours

Industry news / 24 August 2015 / Victoria White

AstraZeneca and Peregrine Pharmaceuticals are to evaluate the safety and efficacy of Peregrine’s bavituximab in combination with AstraZeneca’s durvalumab…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +